Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 17

1.

Donor Factors Including Donor Risk Index Predict Fibrosis Progression, Allograft Loss, and Patient Survival following Liver Transplantation for Hepatitis C Virus.

Jesudian A, Desale S, Julia J, Landry E, Maxwell C, Kallakury B, Laurin J, Shetty K.

J Clin Exp Hepatol. 2016 Jun;6(2):109-14. doi: 10.1016/j.jceh.2015.10.005. Epub 2015 Nov 12.

PMID:
27493458
2.

Advances in liver transplantation allocation systems.

Schilsky ML, Moini M.

World J Gastroenterol. 2016 Mar 14;22(10):2922-30. doi: 10.3748/wjg.v22.i10.2922. Review.

3.

The corrected donor age for hepatitis C virus-infected liver transplant recipients.

Dirchwolf M, Dodge JL, Gralla J, Bambha KM, Nydam T, Hung KW, Rosen HR, Feng S, Terrault NA, Biggins SW.

Liver Transpl. 2015 Aug;21(8):1022-30. doi: 10.1002/lt.24194.

4.

Aging impairs induction of redox factor-1 after heat stress: a potential mechanism for heat-induced liver injury.

Sholomskas LM, Roche KL, Bloomer SA.

Int J Physiol Pathophysiol Pharmacol. 2015 Mar 20;7(1):14-26. eCollection 2015.

5.

Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation.

Gitto S, Belli LS, Vukotic R, Lorenzini S, Airoldi A, Cicero AF, Vangeli M, Brodosi L, Panno AM, Di Donato R, Cescon M, Grazi GL, De Carlis L, Pinna AD, Bernardi M, Andreone P.

World J Gastroenterol. 2015 Apr 7;21(13):3912-20. doi: 10.3748/wjg.v21.i13.3912.

6.

MicroRNAs in Liver Disease: Bench to Bedside.

Shah N, Nelson JE, Kowdley KV.

J Clin Exp Hepatol. 2013 Sep;3(3):231-42. doi: 10.1016/j.jceh.2013.09.001. Epub 2013 Sep 17.

7.

Post-liver transplant hepatitis C virus recurrence: an unresolved thorny problem.

Grassi A, Ballardini G.

World J Gastroenterol. 2014 Aug 28;20(32):11095-115. doi: 10.3748/wjg.v20.i32.11095. Review.

8.

Restricting liver transplant recipients to younger donors does not increase the wait-list time or the dropout rate: the hepatitis C experience.

Flemming JA, Vagefi PA, Freise CE, Yao FY, Terrault NA.

Liver Transpl. 2014 Oct;20(10):1202-10. doi: 10.1002/lt.23937. Epub 2014 Sep 3.

9.

Predictors of disease recurrence post living donor liver transplantation in end stage chronic HCV patients.

El Awady MK, Bader El Din NG, Abdel Aziz Riad M, Omran MH, Abdelhafez TH, Elbaz TM, Hunter SS, Dawood RM, Abdel Aziz AO.

Dis Markers. 2014;2014:202548. doi: 10.1155/2014/202548. Epub 2014 Feb 18.

10.

Histopathological evaluation of recurrent hepatitis C after liver transplantation: a review.

Vasuri F, Malvi D, Gruppioni E, Grigioni WF, D'Errico-Grigioni A.

World J Gastroenterol. 2014 Mar 21;20(11):2810-24. doi: 10.3748/wjg.v20.i11.2810. Review.

11.

Matching donor to recipient in liver transplantation: Relevance in clinical practice.

Reddy MS, Varghese J, Venkataraman J, Rela M.

World J Hepatol. 2013 Nov 27;5(11):603-11. doi: 10.4254/wjh.v5.i11.603. Review.

12.
13.

Living-donor liver transplantation and hepatitis C.

Akamatsu N, Sugawara Y.

HPB Surg. 2013;2013:985972. doi: 10.1155/2013/985972. Epub 2013 Jan 21.

14.

Liver transplantation and hepatitis C.

Akamatsu N, Sugawara Y.

Int J Hepatol. 2012;2012:686135. doi: 10.1155/2012/686135. Epub 2012 Jul 26.

15.

Elderly recipients of hepatitis C positive renal allografts can quickly develop liver disease.

Flohr TR, Bonatti H, Hranjec T, Keith DS, Lobo PI, Kumer SC, Schmitt TM, Sawyer RG, Pruett TL, Roberts JP, Brayman KL.

J Surg Res. 2012 Aug;176(2):629-38. doi: 10.1016/j.jss.2011.10.028. Epub 2011 Nov 19.

16.

Recipient outcomes after ABO-incompatible liver transplantation: a systematic review and meta-analysis.

Wu J, Ye S, Xu X, Xie H, Zhou L, Zheng S.

PLoS One. 2011 Jan 25;6(1):e16521. doi: 10.1371/journal.pone.0016521. Review.

17.

Recent advances in liver transplantation for the practicing gastroenterologist.

Mascarenhas R, Gurakar A.

Gastroenterol Hepatol (N Y). 2009 Jun;5(6):443-50.

Items per page

Supplemental Content

Write to the Help Desk